CIK 0001815442
- Large accelerated filer
Kymera Therapeutics, Inc.
Sign in to watch- Ticker
- KYMR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 812992166
- Phone
- +1 857-285-5314
- Business address
- 500 NORTH BEACON STREET, 4TH FLOOR, WATERTOWN, MA, 02472
- Former names
- Kymera Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,158,214
- in 2 filings, $3.4M under 10b5-1 plans
Net −$4,158,214. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 68 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-03-15 | Booth Bruce Director | Sale 10b5-1 | −1,593 | $41.23 | $66K | 4,570,665 |
| 2024-03-15 | Booth Bruce Director | Sale 10b5-1 | −1,714 | $39.31 | $67K | 817,437 |
| 2024-03-15 | Booth Bruce Director | Sale 10b5-1 | −10,411 | $40.62 | $423K | 807,026 |
| 2024-03-15 | Booth Bruce Director | Sale 10b5-1 | −329 | $41.23 | $14K | 806,697 |
| 2024-03-14 | Booth Bruce Director | Sale 10b5-1 | −34,473 | $39.73 | $1.4M | 4,641,602 |
| 2024-03-14 | Booth Bruce Director | Sale 10b5-1 | −10,846 | $40.66 | $441K | 4,630,756 |
| 2024-03-14 | Booth Bruce Director | Sale 10b5-1 | −781 | $41.51 | $32K | 4,629,975 |
| 2024-03-14 | Booth Bruce Director | Sale 10b5-1 | −7,292 | $39.73 | $290K | 821,538 |
| 2024-03-14 | Booth Bruce Director | Sale 10b5-1 | −2,233 | $40.66 | $91K | 819,305 |
| 2024-03-14 | Booth Bruce Director | Sale 10b5-1 | −154 | $41.51 | $6K | 819,151 |
| 2024-03-13 | Atlas Venture Fund X, L.P. 10% owner | Sale 10b5-1 | −108,404 | $42.19 | $4.6M | 4,682,761 |
| 2024-03-13 | Atlas Venture Fund X, L.P. 10% owner | Sale 10b5-1 | −6,686 | $42.84 | $286K | 4,676,075 |
| 2024-03-13 | Atlas Venture Fund X, L.P. 10% owner | Sale 10b5-1 | −22,779 | $42.19 | $961K | 830,216 |
| 2024-03-13 | Atlas Venture Fund X, L.P. 10% owner | Sale 10b5-1 | −1,386 | $42.84 | $59K | 828,830 |
| 2024-03-13 | Booth Bruce Director | Sale 10b5-1 | −108,404 | $42.19 | $4.6M | 4,682,761 |
| 2024-03-13 | Booth Bruce Director | Sale 10b5-1 | −6,686 | $42.84 | $286K | 4,676,075 |
| 2024-03-13 | Booth Bruce Director | Sale 10b5-1 | −22,779 | $42.19 | $961K | 830,216 |
| 2024-03-13 | Booth Bruce Director | Sale 10b5-1 | −1,386 | $42.84 | $59K | 828,830 |
| 2024-03-12 | Atlas Venture Fund X, L.P. 10% owner | Sale 10b5-1 | −126,066 | $41.94 | $5.3M | 4,799,746 |
| 2024-03-12 | Atlas Venture Fund X, L.P. 10% owner | Sale 10b5-1 | −8,581 | $42.52 | $365K | 4,791,165 |
Page 28 of 41 · 810 trades